Replies to post #4894 on Insmed Inc (INSM)

[windyducat]

buy4long,

In all due respect I disagree. They made a settlement and want to move forward with no overhang. IMO any rehashing the past or ligitation for a very small indictaion only gets in the way of their singluar goal of a broader indication. Short stature was a means to FDA approval and IMO only a stepping stone to something bigger. The best scenario is doctors continue to prescribe Iplex and we recover some of our manufacturing cost and all parties are happy. Doctors, parents, children, Isnmed and Tercica.